Articles

ChemPartner Articles

October 6, 2020ChemPartner BlogBlog

Discovery of the Hepatitis C Virus -The 2020 Nobel Prize in Physiology or Medicine

By: Dr. Jie Jack Li, Vice President of Discovery Chemistry at ChemPartner On October 5, 2020, the N... See more »
June 30, 2020ChemPartner BlogBlog

The Story of Dexamethasone

By: Dr. Jie Jack Li, Vice President of Discovery Chemis [...]... See more »
June 16, 2020Contract PharmaNews

ChemPartner Expands Biologics Capabilities

Makes additional investments in biologics from research to manufacturing capabilities... See more »
June 10, 2020FinanzNachrichtenNews

ChemPartner Makes Additional Investments in Biologics from Research to Manufacturing Capabilities

SHANGHAI, June 10, 2020 /PRNewswire/ -- Shanghai ChemPartner announced the additional investments the... See more »
June 1, 2020ChemPartner BlogBlog

How Is Remdesivir Made?

By: Dr. Jie Jack Li, Vice President of Discovery Chemis [...]... See more »
May 26, 2020ChemPartner BlogBlog

Genesis of Remdesivir

By: Dr. Jie Jack Li, Vice President of Discovery Chemis [...]... See more »
May 12, 2020FinanzNachrichtenNews

ChemPartner Assists the Mount Sinai Health System in Producing Reagent for COVID-19 Research

SHANGHAI, May 12, 2020 /PRNewswire/ -- Shanghai ChemPartner announced they have entered into a non-ex... See more »
May 1, 2020ChemPartner BlogBlog

How Does Remdesivir Work?

By: Dr. Jie Jack Li, Vice President of Discovery Chemis [...]... See more »
April 16, 2020ChemPartner BlogBlog

ChemPartner and the Gladstone Institutes Announce COVID-19 Research Collaboration

SAN FRANCISCO, Calif. and SHANGHAI, China. (April 15, 2 [...]... See more »
April 1, 2020ChemPartner BlogBlog

ChemPartner Introduces New State-of-the-Art Global Operation Center in Shanghai

Shanghai, China (March 17, 2020) - Shanghai ChemPartner [...]... See more »
March 20, 2020Contract PharmaNews

ChemPartner Expands China Ops

Introduces new state-of-the-art global operation center in Shanghai... See more »
March 20, 2020Biospectrum AsiaNews

ChemPartner introduces new operation centre in Shanghai

The building, operating as ChemPartner's new Global Operation Center, houses approximately 700 employ... See more »
September 19, 2019ChemPartner BlogBlog

Meeting Chiral Separation Efficiency Needs in Pharmaceutical Discovery with Supercritical Fluid Chromatography

By: Dr. Manny Ventura, Director and Global Head of Anal [...]... See more »
July 18, 2019ChemPartner BlogBlog

Shanghai ChemPartner was awarded "TOP 10 CMOs in 2019"

Contract manufacturers play a significant role when it [...]... See more »
May 18, 2019BioPortfolioNews

ChemPartner Adds B Cell Discovery from Berkeley Lights to Offerings

Shanghai ChemPartner a China CRO extended its collaboration with Berkeley Lights Inc. of South San Fr... See more »
April 17, 2019ChemPartner BlogBlog

Innovations in Lead Generation Through Fragment-Based Screening

By: Dr. Kevin Greenman, Principal Scientist at ChemPart [...]... See more »
October 5, 2018BioPortfolioNews

Shanghai ChemPartner Co Ltd Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 24072018 Prices from USD $250

SummaryShanghai ChemPartner Co Ltd ChemPartner is a life science contract research organization. The ... See more »
August 19, 2018BioPortfolioNews

Week in Review Shanghai ChemPartner a China CROCMO Completes Reverse Merger

Deals and Financings Shanghai ChemPartner a CROCMO closed its reverse merger with Quantum HiTech Chin... See more »
August 13, 2018BioPortfolioNews

Shanghai ChemPartner Co Ltd Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 14062018 Prices from USD $250

SummaryShanghai ChemPartner Co Ltd ChemPartner is a life science contract research organization. The ... See more »
April 17, 2018ForImmediateReleasePress Release

The 2017 Best Life Science Contract Research Organization (CRO), ChemPartner, Chooses CAS SciFinder® to Enable Closer Collaboration with Customers

Travel & Tourism Industry release: COLUMBUS, Ohio, April 16, 2018 /PRNewswire/ - CAS, a division of t... See more »
April 1, 2018BioPortfolioNews

Shanghai ChemPartner Co Ltd Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 14032018 Prices from USD $250

SummaryShanghai ChemPartner Co Ltd ChemPartner is a life science contract research organization. The ... See more »
October 25, 2017PR NewswirePress Release

Shanghai ChemPartner Sponsors Peptide Therapeutic Foundation

SHANGHAI, Oct. 25, 2017 /PRNewswire/ -- Shanghai ChemPartner today announced their sponsorship of the... See more »
July 11, 2017streetinsiderPress Release

Dr. Lilly Xu joins ChemPartner as Vice President and Head of DMPK and Exploratory Toxicology

Shanghai ChemPartner today announced the appointment of Lilly Xu, Ph.D. as Vice President and the Hea... See more »
June 19, 2017PR Newswire AsiaPress Release

ShangPharma Announces Second Milestone in Move to Enter Chinese Capital Market

SHANGHAI, June 19, 2017 /PRNewswire/ -- ShangPharma, a leading life science partnering organization p... See more »
August 2, 2016PR Newswire AsiaPress Release

ChemPartner and Trianni Announce Partnering Agreement

SAN FRANCISCO, Aug. 2, 2016 /PRNewswire/ -- Trianni, Inc. ("TRIANNI") and ChemPartner, a leading scie... See more »
October 29, 2015ChemPartner Youtube ChannelVideo

"ChemPartner - Dedicated to Life Science" on YOUTUBE

July 2, 2015FREE PR NOWPress Release

The obviously advantages of the high tech therapeutic antibody engineering

Therapeutic antibody engineering refers to engineer which making use of recombinant DNA and protein e... See more »
May 25, 2015PR FREE.ORGPress Release

The advantages of the new recombinant antibody technology

In recent years, with the development of immunology and clarify molecular biology techniques and the ... See more »
April 22, 2015LISTFREE.ORGPress Release

Tell you basically information about the Therapeutic antibody engineering

America-Antibody engineering refer to the using of recombinant DNA and protein engineering techniques... See more »
Loading interface...
Loading interface...
Loading interface...
Loading interface...